CT Imaging and Clinical Features to Predict Outcomes in Patients With Gastric Cancer
Part of Cancer, Digestive system clinical trials.
The goal of this prospective observational study is to evaluate how well a previously developed prediction model can estimate outcomes in adults with gastric cancer. The model combines information from computed tomography (CT) images obtained before treatment with routine clinical information. The main questions are how well the model predicts how long participants live after treatment begins and whether their cancer progresses. Participants will receive their usual medical care. Researchers will collect pretreatment CT images, basic clinical and tumor information, laboratory and tumor marker results, treatment information, and follow-up outcomes obtained during routine care. These data will be entered into the predefined prediction model, and the model's predictions will be compared with what actually happens during follow-up. The study will not change the participants' usual treatment. Model predictions will be used for research purposes only and will not be used to make treatment decisions.
Summary from the official registry record.
Who can take part
- Histologically or pathologically confirmed gastric cancer and receiving treatment at the study center.
- Age ≥18 years.
- Complete pretreatment CT imaging data available from the study center.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses information from CT scans done before stomach cancer surgery to see if it can predict whether the cancer may come back early. Researchers want to find patterns in the scans that might help doctors plan better follow-up care.
This trial uses a combination of CT scans, ultrasound, and blood tests to predict how well chemotherapy will work for people with locally advanced gastric cancer. The goal is to personalize treatment by identifying who will respond best to neoadjuvant chemotherapy.
This trial uses a special type of CT scan (spectral CT) to get a more accurate picture of how far your stomach cancer has spread. The goal is to help doctors choose the best treatment for you.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This trial looks at two types of scans—18F-FAPI PET/CT and MRI—to see how they compare for people with suspected or diagnosed gastric cancer. The goal is to learn which scan gives better information to help guide care.
This study uses a special type of ct scan (energy ct) to help doctors see stomach cancer more clearly. If you have been diagnosed with stomach cancer and are scheduled for surgery, this imaging test may help guide your treatment.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.